755 related articles for article (PubMed ID: 15231980)
1. Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis.
Langley JM; Halperin SA; Boucher FD; Smith B;
Pediatrics; 2004 Jul; 114(1):e96-101. PubMed ID: 15231980
[TBL] [Abstract][Full Text] [Related]
2. A randomized, placebo-controlled trial of erythromycin estolate chemoprophylaxis for household contacts of children with culture-positive bordetella pertussis infection.
Halperin SA; Bortolussi R; Langley JM; Eastwood BJ; De Serres G
Pediatrics; 1999 Oct; 104(4):e42. PubMed ID: 10506267
[TBL] [Abstract][Full Text] [Related]
3. Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections.
Halperin SA; Bortolussi R; Langley JM; Miller B; Eastwood BJ
Pediatrics; 1997 Jul; 100(1):65-71. PubMed ID: 9200361
[TBL] [Abstract][Full Text] [Related]
4. Antibiotics for whooping cough (pertussis).
Altunaiji S; Kukuruzovic R; Curtis N; Massie J
Cochrane Database Syst Rev; 2005 Jan; (1):CD004404. PubMed ID: 15674946
[TBL] [Abstract][Full Text] [Related]
5. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
[TBL] [Abstract][Full Text] [Related]
6. Antibiotics for whooping cough (pertussis).
Altunaiji S; Kukuruzovic R; Curtis N; Massie J
Cochrane Database Syst Rev; 2007 Jul; (3):CD004404. PubMed ID: 17636756
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of clarithromycin versus erythromycin for the treatment of pertussis: a prospective, randomized, single blind trial.
Lebel MH; Mehra S
Pediatr Infect Dis J; 2001 Dec; 20(12):1149-54. PubMed ID: 11740322
[TBL] [Abstract][Full Text] [Related]
8. Comparison of erythromycin estolate and erythromycin ethylsuccinate for treatment of pertussis. The Erythromycin Study Group.
Hoppe JE
Pediatr Infect Dis J; 1992 Mar; 11(3):189-93. PubMed ID: 1565532
[TBL] [Abstract][Full Text] [Related]
9. Clinical validation of a polymerase chain reaction assay for the diagnosis of pertussis by comparison with serology, culture, and symptoms during a large pertussis vaccine efficacy trial.
Heininger U; Schmidt-Schläpfer G; Cherry JD; Stehr K
Pediatrics; 2000 Mar; 105(3):E31. PubMed ID: 10699133
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin.
Aoyama T; Sunakawa K; Iwata S; Takeuchi Y; Fujii R
J Pediatr; 1996 Nov; 129(5):761-4. PubMed ID: 8917247
[TBL] [Abstract][Full Text] [Related]
11. Compliance with azithromycin versus erythromycin in the setting of a pertussis outbreak.
Devasia RA; Jones TF; Collier B; Schaffner W
Am J Med Sci; 2009 Mar; 337(3):176-8. PubMed ID: 19301451
[TBL] [Abstract][Full Text] [Related]
12. A controlled study of the relationship between Bordetella pertussis infections and sudden unexpected deaths among German infants.
Heininger U; Kleemann WJ; Cherry JD;
Pediatrics; 2004 Jul; 114(1):e9-15. PubMed ID: 15231967
[TBL] [Abstract][Full Text] [Related]
13. [Detection of Bordetella pertussis infection by culture, real-time polymerase chain reaction and serologic tests among children with prolonged cough].
Gürsel D; Aslan A; Sönmez C; Koturoğlu G; Cöplü N; Kurugöl Z; Aydemir S
Mikrobiyol Bul; 2012 Apr; 46(2):211-24. PubMed ID: 22639310
[TBL] [Abstract][Full Text] [Related]
14. Short-term treatment of pertussis with azithromycin in infants and young children.
Baće A; Zrnić T; Begovac J; Kuzmanović N; Culig J
Eur J Clin Microbiol Infect Dis; 1999 Apr; 18(4):296-8. PubMed ID: 10385021
[TBL] [Abstract][Full Text] [Related]
15. Surveillance for transmission and antibiotic adverse events among neonates and adults exposed to a healthcare worker with pertussis.
Friedman DS; Curtis CR; Schauer SL; Salvi S; Klapholz H; Treadwell T; Wortzman J; Bisgard KM; Lett SM
Infect Control Hosp Epidemiol; 2004 Nov; 25(11):967-73. PubMed ID: 15566032
[TBL] [Abstract][Full Text] [Related]
16. Measures to control an outbreak of pertussis in a neonatal intermediate care nursery after exposure to a healthcare worker.
Bryant KA; Humbaugh K; Brothers K; Wright J; Pascual FB; Moran J; Murphy TV
Infect Control Hosp Epidemiol; 2006 Jun; 27(6):541-5. PubMed ID: 16755471
[TBL] [Abstract][Full Text] [Related]
17. Clinical and laboratory diagnosis of pertussis in the regions of a large vaccine efficacy trial in Germany.
Heininger U; Cherry JD; Eckhardt T; Lorenz C; Christenson P; Stehr K
Pediatr Infect Dis J; 1993 Jun; 12(6):504-9. PubMed ID: 8345982
[TBL] [Abstract][Full Text] [Related]
18. Five days of erythromycin estolate versus ten days of penicillin V in the treatment of group A streptococcal tonsillopharyngitis in children. Pharyngitis Study Group.
Adam D; Scholz H
Eur J Clin Microbiol Infect Dis; 1996 Sep; 15(9):712-7. PubMed ID: 8922570
[TBL] [Abstract][Full Text] [Related]
19. Multicenter, randomized, double-blind comparison of erythromycin estolate versus amoxicillin for the treatment of acute otitis media in children. AOM Study Group.
Scholz H; Noack R
Eur J Clin Microbiol Infect Dis; 1998 Jul; 17(7):470-8. PubMed ID: 9764549
[TBL] [Abstract][Full Text] [Related]
20. Erythromycin in the treatment of pertussis: a study of bacteriologic and clinical effects.
Bergquist SO; Bernander S; Dahnsjö H; Sundelöf B
Pediatr Infect Dis J; 1987 May; 6(5):458-61. PubMed ID: 2885802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
